Pilecki Derek Steven purchased $12K of GROW (indirect holdings)

Pilecki Derek Steven purchased 4,532 indirectly-held shares of U S GLOBAL INVESTORS INC (GROW) at $2.58 on 2026-10-23.

Original reporting
SEC EDGAR · Pilecki Derek Steven
Published Oct 26, 2026, 6:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 6:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$GROW
Neutral
high confidence
Mentioned
$GROW
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$GROWNeutralLow
01

Why it matters

The disclosed purchase is modest in size, offering limited actionable insight for traders.

02

Market read

Minor insider purchase with negligible immediate market impact.

03

What to watch

Potential upcoming corporate actions or earnings that may have prompted the insider to increase holdings.

Relevance 3/10Novelty 3/10Timing: after-hours filing on 2026-10-26

Background

SEC Form 4 filings disclose insider transactions and are considered primary sources of corporate insider activity.

Company-level read

Ticker impact

$GROWNeutralHigh confidence
Context

SEC Form 4 shows insider Derek Pilecki bought 4,532 shares of US Global Investors at $2.5799, increasing his stake to over 1.1 million shares.

Expected impact

likely slight upward pressure as market digests insider buying

Evidence & confidence

The transaction is a primary disclosure, but the $12K amount is trivial for a listed company, so any price move would be minimal.

Market effects

None; the filing pertains only to the company itself.

None; no broader regional effect.

None; limited to US Global Investors shareholders.

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a strong endorsement.

Key entities

  • Derek Pilecki

    Reporter of the Form 4 transaction.

  • US Global Investors Inc.

    Issuer of the shares purchased.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GROWMed

U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Reports 18% Revenue Growth and Returns to Operating Profitability in First Quarter of Fiscal 2027 *****************

$GROWMed

U.S. Global Investors Reports $3.1 Million in Net Income for Fiscal Year 2026

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Reports $3.1 Million in Net Income for Fiscal Year 2026 ***********************************************************

$GROWLow

U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Strength Remains Unchanged

U S GLOBAL INVESTORS INC (GROW) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973695.htm EXHIBIT 99.1 ex_973695.htm Exhibit 99.1 Contact: Holly Schoenfeldt Director of Marketing and Public Relations 210.308.1268 hschoenfeldt@usfunds.com For Immediate Release U.S. Global Investors Announces Restatement of EPS for Q3 2026; Reported Financial Str

$GROWMedAI 8/10

U.S. Global Investors Announces Intent to Restate EPS for the March 31, 2026, Financial Statements; Underlying Financial Results Unchanged

U.S. Global Investors (NASDAQ: GROW) said it will restate EPS for the three- and nine-month periods ended March 31, 2026, due to a miscalculation of basic and diluted weighted-average shares that omitted a component in a supporting spreadsheet. The company said net income, revenues, operating income, cash, and other line items are unchanged. For the quarter, EPS was overstated by $0.02; corrected basic/diluted EPS is $0.21. For nine months, overstated by $0.01; corrected EPS is reflected in an a